Corona Virus
Stay Safe, FollowGuidance
Fetching Location Data…
James Hyerczyk
Asia-Pacific Shares

The major Asia-Pacific stock indexes finished mixed on Friday as investors continued to assess the impact of the new surge of coronavirus cases on the global economic recovery.

Japan’s Nikkei finished lower following the release of a report on core consumer inflation. Australia was pressured by a weak financial sector. China held its lending benchmark loan prime rate steady for the 7th straight month, in line with market expectations.


In the cash market on Friday, Japan’s Nikkei 225 Index settled at 25527.37, down 106.97 or -0.42%. Hong Kong’s Hang Seng Index finished at 26451.54, up 94.57, up +0.36% and South Korea’s KOSPI Index closed at 2553.50, up 6.08 or +0.24%.

China’s Shanghai Index settled at 3377.73, up 14.64 or +0.44% and Australia’s S&P/ASX 200 Index closed at 6539.20, down 8.00 or -0.12%.

Japan’s Consumer Prices Fall at Fastest Pace in Decade, Reviving Deflation Fears

Japan’s core consumer prices fell in October at their fastest annual pace in nearly a decade as the boost from last year’s sales tax hike petered out, heightening fears of a return to deflation for an economy still dealing with COVID-19.

Analysts expect consumer prices to continue falling in coming months due to sluggish consumption, casting doubt on the central bank’s view Japan will eventually see prices bounce back towards the central bank’s elusive 2% inflation target.


China Keeps Lending Benchmark Loan Prime Rate Steady for 7th Straight Month as Expected

China left its benchmark lending rate for corporate and household loans unchanged for a seventh straight month at its November fixing on Friday, matching market expectations.

The one-year loan prime rate (LPR) was kept unchanged at 3.85%, while the five-year LPR remained at 4.65%.

Hong Kong Shares Edge Up on Consumer and Material Boost; Post Third Consecutive Weekly Gain

Hong Kong shares edged up on Friday to post their third consecutive weekly advance, led by consumer and material stocks, tracking mainland gains on upbeat data and policy support during the week.

The top gainer on the Hang Seng was WuXi Biologics Inc, which gained 5.57%, while the biggest loser was China Overseas Land & Investment Ltd, which fell 3.79%.

For the week, the HIS rose 1.13%, while the HSCE up 0.1%, as investors cheered news of Beijing’s pledge to boost domestic consumption and promote an innovation-driven growth model to salvage a pandemic-ravaged economy.

China will promote economic growth to a “reasonable” range while pursuing higher quality development, Premier Li Keqiang was quoted as saying on Tuesday night by state radio.

For a look at all of today’s economic events, check out our economic calendar.

Don't miss a thing!
Discover what's moving the markets. Sign up for a daily update delivered to your inbox

Trade With A Regulated Broker

  • Your capital is at risk
The content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your own due diligence checks, apply your own discretion and consult your competent advisors. The content of the website is not personally directed to you, and we does not take into account your financial situation or needs.The information contained in this website is not necessarily provided in real-time nor is it necessarily accurate. Prices provided herein may be provided by market makers and not by exchanges.Any trading or other financial decision you make shall be at your full responsibility, and you must not rely on any information provided through the website. FX Empire does not provide any warranty regarding any of the information contained in the website, and shall bear no responsibility for any trading losses you might incur as a result of using any information contained in the website.The website may include advertisements and other promotional contents, and FX Empire may receive compensation from third parties in connection with the content. FX Empire does not endorse any third party or recommends using any third party's services, and does not assume responsibility for your use of any such third party's website or services.FX Empire and its employees, officers, subsidiaries and associates, are not liable nor shall they be held liable for any loss or damage resulting from your use of the website or reliance on the information provided on this website.
This website includes information about cryptocurrencies, contracts for difference (CFDs) and other financial instruments, and about brokers, exchanges and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and come with a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money.FX Empire encourages you to perform your own research before making any investment decision, and to avoid investing in any financial instrument which you do not fully understand how it works and what are the risks involved.